TP53 haplotype-based analysis and incidence of post-angioplasty restenosis

Human Genetics

Volumn 114, Issue 4, 2004, Pages 386-390

  Zee, Robert Y L ^a   Cook, Nancy R ^a   Kim, Chung Ah ^a   Fernandez Cruz, Arturo ^b   Lindpaintner, Klaus ^c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^c F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENETIC ANALYSIS; GENETIC MARKER; HAPLOTYPE; HUMAN; INCIDENCE; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTECTION; QUANTITATIVE ANALYSIS; RESTENOSIS;

AGED; ALLELES; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COHORT STUDIES; CORONARY RESTENOSIS; FEMALE; GENE FREQUENCY; GENES, P53; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 1542285374     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-003-1080-8     Document Type: Article

References (23)

1. Aoki M, Morishita R, Matsushita H, Hayashi S, Nakagami H, Yamamoto K, Moriguchi A, Kaneda Y, Higaki J, Ogihara T (1999) Inhibition of the p53 tumor suppressor gene results in growth of human aortic vascular smooth muscle cells. Potential role of p53 in regulation of vascular smooth muscle cell growth. Hypertension 34:192-200
2. Ara S, Lee PS, Hansen MF, Saya H (1990) Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res 18:4961
3. Chan AW, Chew DP, Lincoff AM (2001) Update on pharmacology for restenosis. Curr Interv Cardiol Rep 3:149-155
4. Isner JM, Kearney M, Bortman S, Passeri J (1995) Apoptosis in human atherosclerosis and restenosis. Circulation 91:2703-2711
5. Kawajiri K, Nakachi K, Imai K, Watanabe J, Hayashi S (1993) Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 14:1085-1089
6. McDaniel T, Carbone D, Takahashi T, Chumakov P, Chang EH, Pirollo KF, Yin J, Huang Y, Meltzer SJ (1991) The MspI polymorphism in intron 6 of p53 (TP53) detected by digestion of PCR products. Nucleic Acids Res 19:4796
7. Mitra S, Chatterjee S, Panda CK, Chaudhuri K, Ray K, Bhattacharyya NP, Sengupta A, Roychoudhury S (2003) Haplotype structure of TP53 locus in Indian population and possible association with head and neck cancer. Ann Hum Genet 67:26-34
8. Niu T, Qin ZS, Xu X, Liu JS (2002) Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. Am J Hum Genet 70:157-169
9. Qin ZS, Niu T, Liu JS (2002) Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet 71:1242-1247
10. Ross JS, Stagliano NE, Donovan MJ, Breitbart RE, Ginsburg GS (2001) Atherosclerosis and cancer: common molecular pathways of disease development and progression. Ann N Y Acad Sci 947:271-292; discussion 292-293
11. Sjalander A, Birgander R, Kivela A, Beckman G (1995) p53 polymorphisms and haplotypes in different ethnic groups. Hum Hered 45:144-149
12. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391-394
13. Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, Leigh IM, Matlashewski G, Banks L (1998) Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393:229-234
14. Takahashi A, Taniguchi T, Ishikawa Y, Yokoyama M (1999) Trani-last inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53. Circ Res 84:543-550
15. Tanaka K, Zou JP, Takeda K, Ferrans VJ, Sandford GR, Johnson TM, Finkel T, Epstein SE (1999) Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells. Circulation 99:1656-1659
16. Terwilliger J, Ott J (1994) Handbook of human genetic linkage. Johns Hopkins University Press, Baltimore
17. Van Belle E, Bauters C, Hubert E, Bodart JC, Abolmaali K, Meurice T, McFadden EP, Lablanche JM, Bertrand ME (1997) Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 96:1454-1460
18. Wallenstein S, Hodge SE, Weston A (1998) Logistic regression model for analyzing extended haplotype data. Genet Epidemiol 15:173-181
19. Wang YC, Lee HS, Chen SK, Chang YY, Chen CY (1999) Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur J Cancer 35:226-230
20. Yair D, Ben Baruch G, Chetrit A, Friedman T, Hirsh Yechezkel G, Gotlieb WH, Fishman A, Beller U, Bar-Am A, Friedman E (2000) p53 and WAF1 polymorphisms in Jewish-Israeli women with epithelial ovarian cancer and its association with BRCA mutations. BJOG 107:849-854
21. Yonemitsu Y, Kaneda Y, Tanaka S, Nakashima Y, Komori K, Sugimachi K, Sueishi K (1998) Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo. Circ Res 82:147-156
22. Zee RY, Hoh J, Cheng S, Reynolds R, Grow MA, Silbergleit A, Walker K, Steiner L, Zangenberg G, Fernandez-Ortiz A, Macaya C, Pintor E, Fernandez-Cruz A, Ott J, Lindpainter K (2002) Multi-locus interactions predict risk for post-PTCA restenosis: an approach to the genetic analysis of common complex disease. Pharmacogenomics J 2:197-201
23. Zehbe I, Voglino G, Wilander E, Genta F, Tommasino M (1999) Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet 354:218-219